Working towards New Drugs against Parasitic Worms in a Public-Development Partnership

Abstract

There is a clear need to develop new and inexpensive drugs to alleviate diseases caused by parasitic worms in animals and humans worldwide. In this article we discuss the roles and advantages of working in public–private partnerships (PPPs) – among academia, industry, and philanthropy – to enable anthelmintic drug discovery.